Lilly and Entos Pharmaceuticals Enter into Research and Collaboration Agreement Supporting Development of Innovative Therapies in Multiple Neurologic Disorders — Combination of Entos’ Fusogenix nucleic acid delivery technology and Lilly’s therapeutic cargo offers potential to overcome a key challenge in delivering nucleic acid therapies to the nervous
Read more →AEGIS LIFE ANNOUNCES START OF PHASE 1/2 TRIAL OF THE ENTOS COVID-19 DNA VACCINE, COVIGENIX VAX-001, WITH FIRST PARTICIPANTS DOSED Published by: Aegis Life Business Wire News Release April 16, 2021 12:26 PM Eastern Daylight Time SAN DIEGO–(BUSINESS WIRE)–Aegis Life, Inc. announced today that the first participants
Read more →ENTOS WORKING WITH APPLIED PHARMACEUTICAL INNOVATION TO ENABLE IN-HOUSE DEVELOPMENT AND MANUFACTURING CAPABILITY OF COVID-19 DNA VACCINE Published by: Aegis Life Entos is working with Applied Pharmaceutical Innovation (API) to ensure secure supply of inputs for its vaccine production and the ability to expand its Edmonton facilities.
Read more →ENTOS ANNOUNCES LAUNCH OF US-BASED SPINOUT COMPANY AEGIS LIFE TO SUPPORT ITS GLOBAL VACCINE COMMERCIALIZATION STRATEGY AND SIGNS LICENSE AGREEMENT WITH NTC TO USE NANOSPLASMID VECTOR TECHNOLOGY IN VACCINES Published by: Aegis Life EDMONTON, AB, October 15, 2020 – Entos Pharmaceuticals (Entos), a Canadian biotechnology company developing
Read more →CYTIVA AND ENTOS PHARMACEUTICALS WORK TOGETHER TO ACCELERATE DEVELOPMENT OF COVID19 VACCINES Published by: Aegis Life July 1, 2020 Cytiva’s Fast Trak process development team will use their expertise to develop a scalable downstream protein purification method for Entos Pharmaceuticals that will enable GMP-production of the Fusogenix
Read more →ENTOS ANNOUNCES SELECTION OF LEAD DNA VACCINE CANDIDATES FOR COVID-19 AND A $4.2M AWARD TO MOVE FORWARD WITH PHASE I/II HUMAN TRIALS Published by: Aegis Life EDMONTON, AB, June 25, 2020 – Entos Pharmaceuticals (Entos), a healthcare biotechnology company developing nucleic acid medicines with its Fusogenix drug delivery platform,
Read more →ENTOS PHARMACEUTICALS PARTNERS WITH PRECISION NANOSYSTEMS TO ENABLE HIGHLY SCALABLE GMP MANUFACTURING OF FUSOGENIX DNA COVID-19 VACCINE Published by: Aegis Life EDMONTON, Alberta, May 7, 2020 — Entos Pharmaceuticals (Entos), a healthcare biotechnology company developing next generation nucleic acid medicines with their Fusogenix delivery platform announced
Read more →ENTOS PHARMACEUTICALS PARTNERS WITH EPIVAX TO DEVELOP A PAN-CORONAVIRUS DNA VACCINE Published by: Aegis Life EDMONTON, Alberta, April 28, 2020 — Entos Pharmaceuticals (Entos), a healthcare biotechnology company that develops next generation nucleic acid medicines using the Fusogenix drug delivery platform, today announced a collaboration with EpiVax,
Read more →